NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE has lower modeled downside risk, despite its lower overall score.

TRS

TriMas Corporation

68
Fundamentals35/ 100
Valuation95/ 100
Upside potential61/ 100
Risk potential23/ 100

TRS has the edge over NKE overall, supported by stronger valuation and stronger modeled upside.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

TRS Fundamentals

MetricStatus
Weak
Healthy
Under pressure
Strong

TRS's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.

TRS PE Valuation

CHEAPFAIREXPENSIVE11x23x34x46x
CHEAPFAIREXPENSIVE11x23x34x46x
LevelPEPriceVs current
Current1.6x$37.62—
Cheap12x$286+661%
Forward19x$37.62—
Fair21x$504+1238%
Expensive33x$795+2012%

Historical ranges are pointers, not guarantees.

TRS has the edge over NKE in the historical PE scenario, which offers more potential upside but is not a forecast.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

TRS Forward outlook

MetricOutlook
Strongly deteriorating
Strong growth
Stable
Strongly improving
Limited
Moderate

TRS has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE trails TRS on modeled risk to reward, with less potential upside relative to its potential downside.

TRS Risk to reward

ScenarioChangePrice
Upside+36%$51.17
Downside-23%$29.05

Calculated from the latest close: $37.62 on Nov 12.

TRS has a better modeled risk to reward balance than NKE, with more potential upside relative to its potential downside.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

TRS Earnings Per Share

Q3 2023: $1.22Q4 2023: $0.97Q1 2024: $0.97Q2 2024: $0.98Q3 2024: $0.64Q4 2024: $0.59Q1 2025: $0.77Q2 2025: $0.91Q3 2025: $1.08Q4 2025: $2.97Q1 2026: $24.07Q2 2026: $24.03Forward: $2.03
Q3 2023: $1.22Q4 2023: $0.97Q1 2024: $0.97Q2 2024: $0.98Q3 2024: $0.64Q4 2024: $0.59Q1 2025: $0.77Q2 2025: $0.91Q3 2025: $1.08Q4 2025: $2.97Q1 2026: $24.07Q2 2026: $24.03Forward: $2.03
QuarterTTM EPSYoY
Forward$2.03-92%
Q2 2026$24.03+2541%
Q1 2026$24.07+3026%
Q4 2025$2.97+403%
Q3 2025$1.08+69%
Q2 2025$0.91-7.1%
Q1 2025$0.77-21%
Q4 2024$0.59-39%
Q3 2024$0.64-48%

TRS has the edge over NKE on earnings, with more consistent year-over-year improvement.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

TRS Quarterly Revenue

Q3 2023: $235MQ4 2023: $210MQ1 2024: $227MQ2 2024: $241MQ3 2024: $229MQ4 2024: $228MQ1 2025: $242MQ2 2025: $275MQ3 2025: $269MQ4 2025: $155MQ1 2026: $168MQ2 2026: $175M
Q3 2023: $235MQ4 2023: $210MQ1 2024: $227MQ2 2024: $241MQ3 2024: $229MQ4 2024: $228MQ1 2025: $242MQ2 2025: $275MQ3 2025: $269MQ4 2025: $155MQ1 2026: $168MQ2 2026: $175M
QuarterRevenueYoY
Q2 2026$174.6M-36%
Q1 2026$168.3M-30%
Q4 2025$155.5M-32%
Q3 2025$269.3M+17%
Q2 2025$274.8M+14%
Q1 2025$241.7M+6.4%
Q4 2024$228.1M+8.8%
Q3 2024$229.4M-2.5%

TRS has the edge over NKE on sales, with more consistent year-over-year improvement.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE has the edge over TRS on cash generation, producing positive trailing cash flow while its opponent burns cash.

TRS Free Cash Flow

Q3 2023: $21MQ4 2023: $11MQ1 2024: −$17MQ2 2024: $8MQ3 2024: $10MQ4 2024: $12MQ1 2025: −$4MQ2 2025: $13MQ3 2025: $23MQ4 2025: $37MQ1 2026: −$25MQ2 2026: −$45M
Q3 2023: $21MQ4 2023: $11MQ1 2024: −$17MQ2 2024: $8MQ3 2024: $10MQ4 2024: $12MQ1 2025: −$4MQ2 2025: $13MQ3 2025: $23MQ4 2025: $37MQ1 2026: −$25MQ2 2026: −$45M
QuarterFree cash flowYoY
Q2 2026-$45M-440%
Q1 2026-$24.6M-$20.9M
Q4 2025$36.8M+204%
Q3 2025$22.8M+125%
Q2 2025$13.2M+76%
Q1 2025-$3.8M+$13.2M
Q4 2024$12.1M+6.7%
Q3 2024$10.2M-52%

TRS's free cash flow has turned negative after years in the green: −$10M over the past year.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has 1.5B diluted shares, about the same as a year ago.

TRS Total Shares

Q3 2023: 42MQ4 2023: 42MQ1 2024: 41MQ2 2024: 41MQ3 2024: 41MQ4 2024: 41MQ1 2025: 41MQ2 2025: 41MQ3 2025: 41MQ4 2025: 40MQ1 2026: 37MQ2 2026: 36M
Q3 2023: 42MQ4 2023: 42MQ1 2024: 41MQ2 2024: 41MQ3 2024: 41MQ4 2024: 41MQ1 2025: 41MQ2 2025: 41MQ3 2025: 41MQ4 2025: 40MQ1 2026: 37MQ2 2026: 36M
PeriodChange %Net change
Quarterly-3.2%-1.2M shares
1 year-12%-4.7M shares
3 years-13%-5.4M shares
5 years-16%-7.1M shares
Available history-20%-9.2M shares

TRS has the edge over NKE on shareholder dilution, with a more favorable share count trend.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

TRS Net Leverage

Q3 2023: 2.6xQ4 2023: 2.9xQ1 2024: 3.1xQ2 2024: 3.2xQ3 2024: 3.6xQ4 2024: 3.4xQ1 2025: 3.3xQ2 2025: 3.0xQ3 2025: 2.7xQ4 2025: 4.5xQ1 2026: -11.5xQ2 2026: -14.4x
Q3 2023: 2.6xQ4 2023: 2.9xQ1 2024: 3.1xQ2 2024: 3.2xQ3 2024: 3.6xQ4 2024: 3.4xQ1 2025: 3.3xQ2 2025: 3.0xQ3 2025: 2.7xQ4 2025: 4.5xQ1 2026: -11.5xQ2 2026: -14.4x
QuarterNet LeverageStatus
Q2 2026-14.4xNet Cash
Q1 2026-11.5xNet Cash
Q4 20254.5xHigh
Q3 20252.7xModerate
Q2 20253.0xElevated
Q1 20253.3xElevated
Q4 20243.4xElevated
Q3 20243.6xElevated

TRS has the edge over NKE on leverage, with a lower net debt burden relative to earnings.

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

TRS Weekly Momentum

MetricValueStatus
RSI45.0Neutral
Stochastic27.0Neutral

TRS's weekly RSI is 45 (neutral) and its Stochastic is 27 (neutral).

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

TRS PE vs Consumer Cyclical Sector

MetricTRSSector medianRelative
PE1.6x18x91% below
PE %04747 pts below

TRS has the edge over NKE on valuation relative to its sector.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

TRS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$38.62.6% below
20 week MA$39.44.4% below
50 week MA$38.21.5% below
100 week MA$33.612% above
200 week MA$29.926% above

TRS has the edge over NKE on trend strength, trading above more of its moving averages.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

TRS Yearly ROI

YearStart priceEnd priceROI
2020$31.2$32.0+2.6%
2021$32.0$34.8+8.5%
2022$34.8$27.8-20%
2023$27.8$25.3-8.7%
2024$25.3$24.6-3%
2025$24.6$36.1+47%
2026 YTD$36.1$37.6+4.1%

TRS has the edge over NKE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key